Article
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
9 Jan 2014
Abstract excerpt
Pluripotent stem cells (PSCs) represent an appealing source from which to develop cell replacement therapies. Different initiatives have been launched to promote their development toward clinical applications. This article will review the main questions that should be considered before translating PSC-derived cardiomyocytes into clinical investigations, including the development of good manufacturing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
